---
title: "COVINGTON PAUL S — Ownership Dossier"
canonical: https://whiteintel.dev/entity/19ca1a35-7491-5358-a6ad-e334c96c34c2
json: https://whiteintel.dev/api/public/dossier/19ca1a35-7491-5358-a6ad-e334c96c34c2
identifier: sec:0001181153
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# COVINGTON PAUL S

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001181153`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/19ca1a35-7491-5358-a6ad-e334c96c34c2  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/19ca1a35-7491-5358-a6ad-e334c96c34c2  

## Ownership & control

### Holdings / subsidiaries

- **PHARMACEUTICAL PRODUCT DEVELOPMENT INC** (officer) — https://whiteintel.dev/entity/5355311a-f37e-53af-a2a1-ebba9290c418
- **FURIEX PHARMACEUTICALS, INC.** (officer) — https://whiteintel.dev/entity/a975742c-62be-5b58-ac65-7344a11a5323

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **COVINGTON PAUL S**. Human view: https://whiteintel.dev/entity/19ca1a35-7491-5358-a6ad-e334c96c34c2 · Structured JSON: https://whiteintel.dev/api/public/dossier/19ca1a35-7491-5358-a6ad-e334c96c34c2._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._